Viral PCR test
OtherViral PCR test regardles of symptoms
NCT Number: NCT06810115
Respiratory viruses are known to be a major cause of morbodity in multiple myeloma patients but prospective long-term sudies are lacking. We analysed 219 multiple myeloma patients that had 554 nasopharingeal swabs with 58 documented viral episodes. Respiratory viruses studied were rhinovirus, enterovirus, parainflienza, respirator, syncytial virus, metapneumovirus, coronavirus, bocavirus, influenza A, influenza B. Clinical data were extracted from a prospectively entered database, medical records were reviewed. We have prospectively studiend patients until May 2019 when we gathered survival data. Lastly because of Covid-19 pandemic when almost no other viral infections were isolated, we analysed clinical course of respiratory infections in patients with multiple myeloma after the pandemic.
Looking for future studies?
Notify MeAll sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other hematological malignancies
-
Viral PCR test regardles of symptoms
Time frame: 1 year
University Medical Centre Ljubljana
Other
Incidence and Clinical Significance of Respiratory Viral Infections in Patients With Multiple Myeloma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07611812
First Relpase, Multiple Mieloma
Pavia, Italy
View Trial DetailsNCT06782854
Chronic Disease, Chronic Lymphocytic Leukemia
Bologna, Italy
View Trial DetailsNCT06795815
Advanced Solid Tumors, Hematologic Diseases
Reggio Emilia, Italy
View Trial DetailsNCT07564128
Blood Protein Disorders, Cardiovascular Diseases
View Trial Details